Form 4: ORIC Director Exercises Stock Options, Boosts Holdings

Oric Pharmaceuticals Director Richard A. Heyman exercised stock options to acquire 32,800 shares of common stock on October 3, 2025.

Summary

• Director Richard A. Heyman, a Director at Oric Pharmaceuticals, Inc. (ORIC), reported changes in his beneficial ownership.
• On October 3, 2025, Heyman exercised stock options to acquire a total of 32,800 shares of common stock.
• Specifically, 31,353 shares were acquired at an exercise price of $1.60 per share.
• An additional 1,447 shares were acquired at an exercise price of $3.75 per share.
• Following these transactions, Heyman directly holds 45,300 shares of Oric Pharmaceuticals common stock.
• Heyman also indirectly beneficially owns 216,272 shares of common stock through RAHD Capital, LLC, where he has voting and investment power.
• Remaining derivative holdings include 33,700 stock options exercisable at $1.60 (expiring 02/28/2028) and 52,253 stock options exercisable at $3.75 (expiring 06/16/2032).

Sentiment

Score: 6

Explanation: The exercise of stock options by a director to acquire shares is generally a neutral to slightly positive signal, indicating the insider is increasing their direct stake in the company, which can be interpreted as confidence in future value, though it's often a pre-planned event for compensation or liquidity.

Positives

• Director Richard A. Heyman increased his direct beneficial ownership of Oric Pharmaceuticals common stock by 32,800 shares through option exercises, which can signal confidence in the company's future prospects.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider transactions, such as option exercises and subsequent share acquisitions by directors, are a routine part of executive compensation and personal investment strategies within the biotechnology and pharmaceutical industry. These filings provide transparency into management's direct stake in the company.

Related Party Transactions

• Richard A. Heyman indirectly beneficially owns 216,272 shares of common stock through RAHD Capital, LLC, where he holds voting and investment power.

Stakeholder Impact

• Shareholders may view the increased direct ownership by a director as a positive signal of management's alignment with shareholder interests and confidence in the company's future.

Key Dates

Recommendation

A director's exercise of stock options to acquire shares is a common event and, while it increases insider ownership, it does not inherently provide enough information to warrant a strong buy or sell recommendation. It can be seen as a neutral to slightly positive signal of confidence, but it's often part of a pre-determined compensation plan or personal financial management, rather than a direct market-timing decision.

Keywords

ORIC, Oric Pharmaceuticals, Insider Transaction, Stock Options, Beneficial Ownership, Director, Equity Acquisition